McCain Foods opens DC in Idaho

On June 3, McCain Foods opened its $200 million expansion of its distribution centre (DC) in Burley, Idaho. The potato processor has been operating in the city since 1997. The 259,000 square-foot expansion is designed to meet market demands.

 

"There's global growth going on in the potato industry and Idaho is the ideal place to grow our business to support that,” said Dale McCarthy, vice president of Integrated Supply Chain with McCain Foods.

 

In addition, another 10,000 to 15,000 acres of potatoes will be required to keep the facility at capacity. More than 730 employees are now at the Burley site. 

 

 

Source:  FreshPlaza.com June 6, 2019

If latest news: 
Check if it is latest news (for "Latest News" page)
Publish date: 
Friday, June 7, 2019

Click to leave a comment

CAPTCHA
For security purposes, please confirm you are not a robot!

RELATED NEWS

Fruit Logistica Innovation Award goes to Yoom tomatoes

The Yoom tomato bred by Syngenta Seeds has been voted the 2020 Innovation of the Year by fair goers to the Fruit Logistica trade show in Berlin.  

U.S. potatoes destined for China

As details are unearthed about the American trade deal with China, growers are learning that processing potatoes could be eligible by February 24, 2020. Last-minute negotiations are anticipated regarding market access protocol. 

E. coli outbreak in romaine lettuce declared over

American food safety authorities declared that as of January 15, 2020, the E. coli outbreak connected to romaine lettuce from Salinas, California is now over. A total of 165 people were sickened. No deaths were reported. 

Fruit Logistica Innovation Award nominees

The showcase of 2020 Innovation Award nominees will be a top attraction in Berlin from Feb 5-7.  One of them is a cross between Chinese green cabbage and broccoli with a distinctive purple stalk. 

Tweaks needed for robotic harvesting of apples

Will 2020 be the year for commercializing robotic harvest of apples? Technical obstacles remain for the companies trialling in New Zealand, Europe and the United States.